Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-026519

General Counsel sold 682 shares at $9.88 ($6,736)

  • General Counsel acquired 1,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-30 Exercise or conversion : show line 1 in the form +1,924 10,722 D
2023-05-01 Sale : show line 2 in the form −682 $9.88 $6,736 10,040 D
Open-market sales · 682 sh · avg $9.88 · $6,736

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,924 21,165 D
Loading xslF345X04/doc4.xml…